REGN - Regeneron Pharmaceuticals Inc. (REGN) Oppenheimer 34th Annual Healthcare Life Sciences Conference (Transcript)
2024-02-14 16:13:07 ET
Regeneron Pharmaceuticals, Inc. (REGN)
Oppenheimer 34th Annual Healthcare Life Sciences Conference
February 14, 2024 1:20 PM ET
Company Participants
Ryan Crowe - SVP, IR
David Snow - SVP, Global Head of Dupixent franchise
Conference Call Participants
Hartaj Singh - Oppenheimer
Presentation
Hartaj Singh
Great. Thank you, everybody, for joining us on the second day here of this track of the Oppenheimer Healthcare Conference of 2024. Got David Snow, the SVP and the Global Head of Dupixent franchise; and Ryan Crowe, the SVP of IR joining us here giving us a presentation, which I'm really looking forward to. Regeneron has been always a constant supporter of ours at our healthcare conferences. Really appreciate having them back.
David will give us an update on DUPIXENT. And then from there, we can jump into our fireside chat or just an overall update on the franchise, and we can jump into the fireside chat after that. So please take it away.
Ryan Crowe
Thank you, Hartaj and always great to be a part of the Oppenheimer Healthcare Conference, and happy Valentine's Day to everybody out there. ....
Regeneron Pharmaceuticals, Inc. (REGN) Oppenheimer 34th Annual Healthcare Life Sciences Conference (Transcript)